Detalles de la búsqueda
1.
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.
Oncologist
; 28(7): 628-632, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37141403
2.
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force.
Value Health
; 26(4): 449-460, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005055
3.
A simulated maximum likelihood procedure for analyzing imprecise trade-off thresholds between the benefits and harms of medicines.
Stat Med
; 41(29): 5612-5621, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36163538
4.
EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma.
Oncologist
; 26(11): 983-987, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34213061
5.
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia.
Oncologist
; 26(3): 242-249, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33486852
6.
EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma.
Oncologist
; 26(1): 70-76, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179377
7.
Ethical Aspects of Regulating Oncology Products.
Recent Results Cancer Res
; 218: 119-134, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019166
8.
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.
Oncologist
; 25(4): e709-e715, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32297447
9.
EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX-351) for the Treatment of Adults with Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes.
Oncologist
; 25(9): e1414-e1420, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32282100
10.
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
Oncologist
; 25(6): e976-e981, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154610
11.
EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma.
Oncologist
; 25(12): 1067-1074, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33026700
12.
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.
Oncologist
; 25(7): e1070-e1076, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154636
13.
EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma.
Oncologist
; 25(10): 894-902, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32339368
14.
The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.
Oncologist
; 25(2): e321-e327, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043764
15.
The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia.
Oncologist
; 24(5): e171-e179, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30898889
16.
Regulatory and Evidence Requirements and the Changing Landscape in Regulation for Marketing Authorisation.
Recent Results Cancer Res
; 213: 169-187, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30543013
17.
EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma.
Oncologist
; 23(5): 594-602, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29371479
18.
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma.
Oncologist
; 23(5): 631-636, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29192015
19.
Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma.
Oncologist
; 23(1): 44-51, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29079638
20.
The European Medicines Agency Review of Carfilzomib for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy.
Oncologist
; 22(11): 1339-1346, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935772